Chiara Ambrogio

Chiara Ambrogio

Company: University of Turin

Job title: Associate Professor

Seminars:

Chair’s Closing Remarks & End of the 5th Annual RAS-Targeted Drug Development Summit 5:30 pm

Read more

day: Conference Day Two

Chair’s Opening Remarks 8:20 am

Read more

day: Conference Day Two

An Overview of the Resistance Mechanisms Against RAS-Targeted Drugs Beyond G12C 12:00 pm

Understanding the resistance profiles of different KRAS mutants to effectively target each mutation Differentiating resistance based on mechanism of action to devise the most effective treatment regimen and potential lines of treatment Combining the resistance profiles with histotype analysis of associated cancers for each mutation to create a holistic resistance profile Exploring feasibility of combination…Read more

day: Day One Track B AM

How to Address Resistance Mechanisms to Increase Response Rates & Durability to Prevent Cancer Recurrence 9:01 am

RAS. Therefore, RAS-targeted drugs apply a strong selective force on cancer, leading to the evolution of resistance. Hence, understanding the mechanisms of resistance, as well as, pre-empting new ones for different RAS therapies, and subsequently, developing strategies to counter them, is vital achieve disease free survival of patients. This workshop will: Review existing literature to…Read more

day: Workshop D

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.